COMMUNIQUÉS West-GlobeNewswire

Telitacicept Demonstrates Clinically Meaningful and Statistically Significant Impact on ESSDAI Compared to Placebo in Late-Breaking China Phase 3 Results in Primary Sjögren’s Disease at ACR 2025
14/10/2025
Telitacicept met primary and all secondary endpoints, demonstrating clinically meaningful improvements in disease activity versus placebo ~71.8% of patients receiving telitacicept 160mg achieved ≥3-point ESSDAI (EULAR [...]
Lexicon Pharmaceuticals Presents Additional Pilavapadin Data in Diabetic Peripheral Neuropathic Pain at 19th Annual Pain Therapeutics Summit
14/10/2025
– Results support advancement of 10 mg dose into Phase 3 development – – End-of-Phase 2 meeting request accepted by U.S. FDA; partnership discussions progressing – THE WOODLANDS, Texas, Oct. 14, 2025 (GLOBE NEWSWIRE [...]
Halda Therapeutics Announces Oral Plenary Presentation on HLD-0915 Clinical Data in Metastatic Castration-Resistant Prostate Cancer (mCRPC) at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics on October 24, 2025
14/10/2025
Plenary Presentation to be Followed by Poster Presentation Highlighting HLD-0915 Clinical Data BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics today announced that new clinical data on HLD-0915, the company [...]
Krystal Biotech Receives FDA Platform Technology Designation for HSV-1 Viral Vector Used in KB801 for the Treatment of Neurotrophic Keratitis
14/10/2025
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology designation to the [...]
Ashvattha Therapeutics Appoints Ophthalmology Veteran Robert J. Dempsey as Interim CEO Following Positive Phase 2 Results and FDA Alignment on Pivotal Program
14/10/2025
FDA agrees with Phase 2b/3 clinical design, including primary endpoint and development approach, providing clear regulatory pathway to conduct two studies under single protocol Dempsey brings proven track record of [...]
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
14/10/2025
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary [...]
Validic to Showcase Dual Solutions at HLTH 2025: Wearable Data API for Digital Health and EHR-Integrated Remote Patient Monitoring for Health Systems
14/10/2025
Platform Serves Two Distinct Markets with Comprehensive Wearable Integration APIs and Epic-Integrated Remote Patient Monitoring with AI-powered Insights STERLING, Va., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Validic today [...]
24/7 Market News - Kraig Labs Working to Make Spider Silk a Once-in-a-Generation Technological Breakthrough
14/10/2025
DENVER, Oct. 14, 2025 (GLOBE NEWSWIRE) -- All the buzz around technology today is centered on Artificial Intelligence, Robotics, Digital Currency ($BTC), and the rare earth minerals used to build them. However, these [...]
American teacher undergoes cardiac treatment in Xiamen
14/10/2025
XIAMEN, China , Oct. 14, 2025 (GLOBE NEWSWIRE) -- Kevin Klein, an American teacher from Xiamen International School, underwent coronary angiography and radio-frequency ablation on Sep 26 at the Xiamen Cardiovascular [...]
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases
14/10/2025
Press Release EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases Through this funding round, the company will initiate the clinical development of its first therapeutic candidate, [...]
Dewpoint Therapeutics Announces Presentation at AACR-NCI-EORTC 2025
14/10/2025
Dewpoint will present one poster at AACR-NCI-EORTC MYC is a highly desirable oncogenic target that historically eluded drug hunters Small molecules that inhibit the oncogenic function of MYC were discovered using [...]
HIV Self-Testing Just Got Faster: FDA Approves the 1-Minute INSTI® HIV Self Test
14/10/2025
The fastest, at-home HIV test is now available in the U.S., expanding access to rapid, private, and convenient self-testing A Major Step Forward in HIV Prevention The INSTI ® HIV Self Test delivers highly accurate [...]
Bicycle Health Grows Leadership Team to Further Expand Access to Opioid Use Disorder Care for Patients in the Criminal Justice System
14/10/2025
Steve Tomlin has decades of experience bringing opioid and substance use disorder care to criminal justice populations BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Bicycle Health , the nation’s largest provider of virtual [...]
Rendever Leads Expansion of Virtual Reality in Hospice Care
14/10/2025
The AgeTech company expands hospice partnerships to enhance end-of-life care with immersive experiences for patients and families BOSTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Rendever , the company leading the industry in [...]
Imprivata Acquires Verosint to Add AI-Powered Risk Signaling to its Leading Enterprise Access Management Platform
14/10/2025
Integration of Verosint Identity Threat Detection & Response with Imprivata Enterprise Access Management will strengthen the company’s advanced and passwordless access strategy to bolster security, improve workflow [...]
ZymoChem Named Startup of the Year by The International Textile Manufacturers Federation
14/10/2025
SAN LEANDRO, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) -- ZymoChem , the materials company decarbonizing the chemical industry through biological manufacturing, announces its recognition as a Startup of the Year by The [...]
Immix Biopharma to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
14/10/2025
LOS ANGELES, CA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that it will present and [...]
Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease
14/10/2025
First-in-class regenerative therapy for diabetic foot ulcers complicated by peripheral artery disease Celularity PDA-002 achieved durable wound healing with just two intramuscular doses As a qualified stem cell therapy [...]
Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze
14/10/2025
– Parties enter into Restructuring Support Agreement; Vireo to bid to acquire control of Schwazze assets – – Schwazze operates 63 dispensaries and 10 manufacturing facilities in Colorado and New Mexico – MINNEAPOLIS, [...]

Pages